Top and Current
Source: (remove) : Sumant Kulkarni
RSSJSONXMLCSV
Top and Current
Source: (remove) : Sumant Kulkarni
RSSJSONXMLCSV
Wed, September 18, 2024
Fri, August 30, 2024
Thu, June 27, 2024
Thu, June 13, 2024
Tue, May 7, 2024
Tue, April 30, 2024
Tue, March 26, 2024
Thu, March 14, 2024
Tue, March 12, 2024
Wed, March 6, 2024
Tue, February 20, 2024
Fri, December 29, 2023
Mon, November 6, 2023
Fri, September 1, 2023
Tue, August 15, 2023
Thu, August 3, 2023
Mon, July 17, 2023
Mon, June 12, 2023
Wed, May 10, 2023
Wed, April 26, 2023
Tue, March 14, 2023
Tue, March 7, 2023
Fri, November 11, 2022
Wed, March 16, 2022
Mon, March 14, 2022
Mon, February 7, 2022
Wed, December 22, 2021
Tue, August 3, 2021
Tue, July 27, 2021
Wed, May 12, 2021
Tue, April 6, 2021
Thu, April 1, 2021
Tue, March 9, 2021
Mon, November 16, 2020
Thu, August 6, 2020
Fri, April 24, 2020
Mon, January 27, 2020
Wed, October 23, 2019
Tue, September 10, 2019
Wed, July 24, 2019
Mon, April 15, 2019
Fri, March 22, 2019
Mon, December 10, 2018
Mon, July 23, 2018
Thu, May 31, 2018
Tue, March 27, 2018
Thu, March 15, 2018
Wed, January 24, 2018
Fri, October 27, 2017
Tue, January 31, 2017
Mon, November 7, 2016
Mon, April 1, 2013
Thu, March 28, 2013
Wed, February 27, 2013
Thu, January 3, 2013
Mon, December 17, 2012

Sumant Kulkarni Maintained (zvra) at Strong Buy with Decreased Target to $22 on, Sep 18th, 2024


Published on 2024-10-28 14:19:47 - WOPRAI, Sumant Kulkarni
  Print publication without navigation


Sumant Kulkarni of Canaccord Genuity, Maintained "Zevra Therapeutics, Inc." (ZVRA) at Strong Buy with Decreased Target from $24 to $22 on, Sep 18th, 2024.

Sumant has made no other calls on ZVRA in the last 4 months.



There are 2 other peers that have a rating on ZVRA. Out of the 2 peers that are also analyzing ZVRA, 0 agree with Sumant's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Sumant


  • Louise Chen of "Cantor Fitzgerald" Reiterated at Buy on, Wednesday, August 14th, 2024
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $18 on, Monday, August 5th, 2024